Everolimus more effective than sirolimus in coronary stents

NEW YORK (Reuters Health) - Mortality rates are similar, but pooled data show other advantages when coronary stents are coated with everolimus rather than sirolimus, researchers say.
Source: Modern Medicine - Category: Journals (General) Source Type: news